Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Tampa FL, Jacksonville FL, Atlanta GA, Birmingham AL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06553885
Phase 2, Recruiting
Avapritinib With Decitabine in Patients With SM-AHN
for
Systemic Mastocytosis With an Associated Hematologic Neoplasm
Location: Tampa FL, Salt Lake City UT
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06327685
Phase 1, Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Tampa FL, Miami FL, Knoxville TN, Winston-Salem NC,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase 3, Recruiting
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
for
Melanoma Stage III, Melanoma Stage IV, Advanced Melanoma,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06295159
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab
for
HER2-positive Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05325632
Phase 2, Recruiting
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
for
Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell Lymphoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06350318
Phase 2, Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma,
Location: Tampa FL, Charleston SC, Charlotte NC, Nashville TN,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT04429542
Phase 1, Recruiting
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
for
Acute Myeloid Leukemia With FLT3/ITD Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05024552
Phase 1, Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
for
Solid Tumor, Adult, Metastatic Breast Cancer,
Location: Tampa FL, Nashville TN, Houston TX, Indianapolis IN,
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
for
HIV Infection, Tobacco-Related Carcinoma
Location: Tampa FL, Houston TX, Washington D.C. DC, Columbus OH,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 45 - 70+
Code: NCT04949464
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Tampa FL, Plantation FL, Nashville TN, Memphis TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase 1, Phase 2, Recruiting
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
for
Metastatic Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: Female
Age: 18+
Code: NCT06409390
Phase 2, Recruiting
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
for
Merkel Cell Carcinoma
Location: Tampa FL, Miami FL, Louisville KY, Houston TX,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03787602
Phase 1, Phase 2, Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Tampa FL, New Orleans LA, Louisville KY, Columbus OH,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: Tampa FL, Miami FL, Atlanta GA, Chapel Hill NC,